Oclacitinib is a novel inhibitor of JAK family members with IC50 ranging from 10 to 99 nM and JAK1-dependent cytokines with IC50 ranging from 36 to 249 nM, which did not inhibit a panel of 38 non-JAK kinases.
MoreAtiprimod dihydrochloride是JAK2 抑制剂。
More1,2,3,4,5,6-Hexabromocyclohexane是抑制 JAK2 自磷酸化。
MoreZM 39923 hydrochloride是活性选择性JAK3抑制剂。
MoreTCS 21311是活性的 JAK3 抑制剂。 也抑制 GSK-3β和PKC。
MoreOclacitinib is a novel inhibitor of JAK family members with IC50 ranging from 10 to 99 nM and JAK1-dependent cytokines with IC50 ranging from 36 to 249 nM, which did not inhibit a panel of 38 non-JAK kinases.
MoreAtiprimod dihydrochloride是JAK2 抑制剂。
More1,2,3,4,5,6-Hexabromocyclohexane是抑制 JAK2 自磷酸化。
MoreZM 39923 hydrochloride是活性选择性JAK3抑制剂。
MoreTCS 21311是活性的 JAK3 抑制剂。 也抑制 GSK-3β和PKC。
MoreOclacitinib is a novel inhibitor of JAK family members with IC50 ranging from 10 to 99 nM and JAK1-dependent cytokines with IC50 ranging from 36 to 249 nM, which did not inhibit a panel of 38 non-JAK kinases.
MoreAtiprimod dihydrochloride是JAK2 抑制剂。
More1,2,3,4,5,6-Hexabromocyclohexane是抑制 JAK2 自磷酸化。
MoreZM 39923 hydrochloride是活性选择性JAK3抑制剂。
MoreTCS 21311是活性的 JAK3 抑制剂。 也抑制 GSK-3β和PKC。
MoreOclacitinib is a novel inhibitor of JAK family members with IC50 ranging from 10 to 99 nM and JAK1-dependent cytokines with IC50 ranging from 36 to 249 nM, which did not inhibit a panel of 38 non-JAK kinases.
MoreAtiprimod dihydrochloride是JAK2 抑制剂。
More1,2,3,4,5,6-Hexabromocyclohexane是抑制 JAK2 自磷酸化。
MoreZM 39923 hydrochloride是活性选择性JAK3抑制剂。
MoreTCS 21311是活性的 JAK3 抑制剂。 也抑制 GSK-3β和PKC。
More